KISUNLA vs MEMANTINE HYDROCHLORIDE

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 23, 2026·How we rate

Possible drug interaction. KISUNLA and MEMANTINE HYDROCHLORIDE are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	KISUNLA	MEMANTINE HYDROCHLORIDE
Rating	70/100	New
Pharmacy pays	—	~$2.46 /30
Type	RX	RX
Active ingredient	DONANEMAB-AZBT	MEMANTINE HYDROCHLORIDE
Manufacturer	Eli Lilly Co	Vitruvias
Dosage forms	Injectable	Capsule, extended release, Kit, Tablet
Drug class	—	N-Methyl-D-Aspartate Receptor Antagonist
Boxed warning	Boxed warning	None
Half-life	—	about 60 to 80 hours
Treats	Alzheimer Disease, Neurocognitive Disorders	Alzheimer Disease

kisunla memantine hydrochloride

Rating

70/100

New

Pharmacy pays

—

~$2.46 /30

Type

Active ingredient

DONANEMAB-AZBT

MEMANTINE HYDROCHLORIDE

Manufacturer

Eli Lilly Co

Vitruvias

Dosage forms

Injectable

Capsule, extended release, Kit, Tablet

Drug class

—

N-Methyl-D-Aspartate Receptor Antagonist

Boxed warning

None

Half-life

—

about 60 to 80 hours

Treats

Alzheimer Disease, Neurocognitive Disorders

Alzheimer Disease

Frequently asked questions

What is the difference between Kisunla and Memantine Hydrochloride?

Kisunla contains Donanemab-Azbt, while Memantine Hydrochloride contains Memantine Hydrochloride — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.